Inhibition of salt inducible kinases reduces rhythmic HIV-1 replication and reactivation from latency.

HIV-1 circadian rhythms host-pathogen interactions salt inducible kinases

Journal

The Journal of general virology
ISSN: 1465-2099
Titre abrégé: J Gen Virol
Pays: England
ID NLM: 0077340

Informations de publication

Date de publication:
08 2023
Historique:
medline: 3 8 2023
pubmed: 2 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

Human immunodeficiency virus type 1 (HIV-1) causes a major burden on global health, and eradication of latent virus infection is one of the biggest challenges in the field. The circadian clock is an endogenous timing system that oscillates with a ~24 h period regulating multiple physiological processes and cellular functions, and we recently reported that the cell intrinsic clock regulates rhythmic HIV-1 replication. Salt inducible kinases (SIK) contribute to circadian regulatory networks, however, there is limited evidence for SIKs regulating HIV-1 infection. Here, we show that pharmacological inhibition of SIKs perturbed the cellular clock and reduced rhythmic HIV-1 replication in circadian synchronised cells. Further, SIK inhibitors or genetic silencing of

Identifiants

pubmed: 37529926
doi: 10.1099/jgv.0.001877
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 200838/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 108869/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R022011/1
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : UM1 AI164567
Pays : United States

Auteurs

Helene Borrmann (H)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Dini Ismed (D)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Anna E Kliszczak (AE)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Persephone Borrow (P)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Sridhar Vasudevan (S)

Department of Pharmacology, University of Oxford, Oxford, UK.

Aarti Jagannath (A)

Sleep and Circadian Neuroscience Institute (SCNi), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Xiaodong Zhuang (X)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Jane A McKeating (JA)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH